These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 25626691)
21. Pharmacological characterization of human excitatory amino acid transporters EAAT1, EAAT2 and EAAT3 in a fluorescence-based membrane potential assay. Jensen AA; Bräuner-Osborne H Biochem Pharmacol; 2004 Jun; 67(11):2115-27. PubMed ID: 15135308 [TBL] [Abstract][Full Text] [Related]
22. Chronic brain ischemia induces the expression of glial glutamate transporter EAAT2 in subcortical white matter. Yatomi Y; Tanaka R; Shimura H; Miyamoto N; Yamashiro K; Takanashi M; Urabe T; Hattori N Neuroscience; 2013 Aug; 244():113-21. PubMed ID: 23602887 [TBL] [Abstract][Full Text] [Related]
23. Current approaches to enhance glutamate transporter function and expression. Fontana AC J Neurochem; 2015 Sep; 134(6):982-1007. PubMed ID: 26096891 [TBL] [Abstract][Full Text] [Related]
24. The role of excitatory amino acid transporter 2 (EAAT2) in epilepsy and other neurological disorders. Alijanpour S; Miryounesi M; Ghafouri-Fard S Metab Brain Dis; 2023 Jan; 38(1):1-16. PubMed ID: 36173507 [TBL] [Abstract][Full Text] [Related]
25. Reduced expression of glutamate transporter EAAT2 and impaired glutamate transport in human primary astrocytes exposed to HIV-1 or gp120. Wang Z; Pekarskaya O; Bencheikh M; Chao W; Gelbard HA; Ghorpade A; Rothstein JD; Volsky DJ Virology; 2003 Jul; 312(1):60-73. PubMed ID: 12890621 [TBL] [Abstract][Full Text] [Related]
26. Benzodiazepines differently modulate EAAT1/GLAST and EAAT2/GLT1 glutamate transporters expressed in CHO cells. Palmada M; Kinne-Saffran E; Centelles JJ; Kinne RK Neurochem Int; 2002 Apr; 40(4):321-6. PubMed ID: 11792462 [TBL] [Abstract][Full Text] [Related]
27. Inducible expression and pharmacology of the human excitatory amino acid transporter 2 subtype of L-glutamate transporter. Dunlop J; Lou Z; Zhang Y; McIlvain HB Br J Pharmacol; 1999 Dec; 128(7):1485-90. PubMed ID: 10602327 [TBL] [Abstract][Full Text] [Related]
34. Role of excitatory amino acid transporter-2 (EAAT2) and glutamate in neurodegeneration: opportunities for developing novel therapeutics. Kim K; Lee SG; Kegelman TP; Su ZZ; Das SK; Dash R; Dasgupta S; Barral PM; Hedvat M; Diaz P; Reed JC; Stebbins JL; Pellecchia M; Sarkar D; Fisher PB J Cell Physiol; 2011 Oct; 226(10):2484-93. PubMed ID: 21792905 [TBL] [Abstract][Full Text] [Related]
35. Mercuric chloride inhibits the in vitro uptake of glutamate in GLAST- and GLT-1-transfected mutant CHO-K1 cells. Mutkus L; Aschner JL; Syversen T; Shanker G; Sonnewald U; Aschner M Biol Trace Elem Res; 2006 Mar; 109(3):267-80. PubMed ID: 16632895 [TBL] [Abstract][Full Text] [Related]
36. The position of an arginine residue influences substrate affinity and K+ coupling in the human glutamate transporter, EAAT1. Ryan RM; Kortt NC; Sirivanta T; Vandenberg RJ J Neurochem; 2010 Jul; 114(2):565-75. PubMed ID: 20477940 [TBL] [Abstract][Full Text] [Related]
37. Up-Regulation of the Excitatory Amino Acid Transporters EAAT1 and EAAT2 by Mammalian Target of Rapamycin. Abousaab A; Uzcategui NL; Elsir B; Lang F Cell Physiol Biochem; 2016; 39(6):2492-2500. PubMed ID: 27855402 [TBL] [Abstract][Full Text] [Related]
38. Proteome analysis and conditional deletion of the EAAT2 glutamate transporter provide evidence against a role of EAAT2 in pancreatic insulin secretion in mice. Zhou Y; Waanders LF; Holmseth S; Guo C; Berger UV; Li Y; Lehre AC; Lehre KP; Danbolt NC J Biol Chem; 2014 Jan; 289(3):1329-44. PubMed ID: 24280215 [TBL] [Abstract][Full Text] [Related]
39. Functional expression, purification and high sequence coverage mass spectrometric characterization of human excitatory amino acid transporter EAAT2. Ye R; Rhoderick JF; Thompson CM; Bridges RJ Protein Expr Purif; 2010 Nov; 74(1):49-59. PubMed ID: 20399272 [TBL] [Abstract][Full Text] [Related]
40. Over-expression of the human EAAT2 glutamate transporter within neurons of mouse organotypic hippocampal slice cultures leads to increased vulnerability of CA1 pyramidal cells. Selkirk JV; Stiefel TH; Stone IM; Naeve GS; Foster AC; Poulsen DJ Eur J Neurosci; 2005 Apr; 21(8):2291-6. PubMed ID: 15869527 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]